WANBURYNSEWANBURY LIMITED· PharmaceuticalsMediumPositive
Announced Mon, 19 Oct, 2026 · 14:35 IST

Wanbury facilities win safety and employer awards

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.4%Reaction day
₹193.50
prior close
₹187.19
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.7%-1.7% vs market
Pharmaceuticals peers, median of 172sector-1.6%-1.8% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.4
15m
-0.2
30m
-0.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.4-1.7-1.7-1.6-1.8
Next day
-3.6-4.2+0.6-3.5-0.2
2d
-4.3-5.2+1.0-3.7-0.6
3d
-8.1-7.4-0.7-5.3-2.8
4d
-12.7-7.0-5.6-4.1-8.6
5d
-8.6-5.5-3.2-2.3-6.3
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Wanbury Limited announced that its Patalganga API facility in Maharashtra received the Certificate of Excellence from the National Safety Council for the third consecutive year, and its Tanuku API facility in Andhra Pradesh was named Best Employer by the State Government. The awards recognise employee practices, workplace culture, and safety performance. The company supplies APIs to over 50 countries with USFDA and EUGMP approved facilities.

Likely market impact

Positive reputational news but no direct financial impact. Reinforces the company's compliance and workplace standards.